Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist® vaccines

Virology

Volumn 380, Issue 2, 2008, Pages 354-362

  Chen, Zhongying ^a   Aspelund, Amy ^a   Kemble, George ^a   Jin, Hong ^a  

^a MEDIMMUNE   (United States)

Author keywords

B Ann Arbor 1 66; Influenza B virus; ts phenotype

Indexed keywords

INFLUENZA VACCINE; RNA POLYMERASE; VIRUS RNA;

ARTICLE; ENZYME ACTIVITY; GENE LOCUS; INFLUENZA VIRUS B; NONHUMAN; NP GENE; PA GENE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TEMPERATURE; TEMPERATURE SENSITIVITY; VIRUS ASSEMBLY; VIRUS GENE; VIRUS REPLICATION; WILD TYPE;

ANIMALS; CELL LINE; DNA-DIRECTED RNA POLYMERASES; DOGS; HEAT; INFLUENZA B VIRUS; INFLUENZA VACCINES; NUCLEOPROTEINS; RNA REPLICASE; RNA, MESSENGER; RNA, VIRAL; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

INFLUENZA B VIRUS; INFLUENZA B VIRUS (STRAIN B/ANN ARBOR/1/66 [WILD-TYPE]);

EID: 53249143947     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.08.010     Document Type: Article

References (51)

1. Ali A., Avalos R.T., Ponimaskin E., and Nayak D.P. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J. Virol. 74 (2000) 8709-8719
2. Ashkenazi S., Vertruyen A., Arístegui J., Esposito S., McKeith D.D., Klemola T., Biolek J., Kühr J., Bujnowski T., Desgrandchamps D., Cheng S.M., Skinner J., Gruber W.C., Forrest B.D., Group, and C.-T.S. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr. Infect. Dis J. 25 (2006) 870-879
3. Baez M., Palese P., and Kilbourne E.D. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J. Infect. Dis. 141 (1980) 362-365
4. Barman S., Ali A., Hui E.K., Adhikary L., and Nayak D.P. Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Res. 77 (2001) 61-69
5. Belshe R.B., and Gruber W.C. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356 1416 (2001) 1947-1951
6. Belshe R., Lee M.S., Walker R.E., Stoddard J., and Mendelman P.M. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert. Rev. Vaccines 3 6 (2004) 643-654
7. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., Kemble G., Connor E.M., Group, and C.-T.C.E.S. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356 (2007) 685-696
8. Bourmakina S.V., and Garcia-Sastre A. Reverse genetics studies on the filamentous morphology of influenza A virus. J. Gen. Virol. 84 (2003) 517-527
9. Carrasco M., Amorim M.J., and Digard P. Lipid raft-dependent targeting of the influenza A virus nucleoprotein to the apical plasma membrane. Traffic 5 12 (2004) 979-992
10. Chan W., Zhou H., Kemble G., and Jin H. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature. Virol. 380 (2008) 304-311
11. Chen Z., Aspelund A., Kemble G., and Jin H. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology 345 2 (2006) 416-423
12. Chen B.J., Leser G.P., Morita E., and Lamb R.A. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 81 13 (2007) 7111-7123
13. Cros J.F., and Palese P. Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res. 95 (2003) 3-12
14. Dalton R.M., Mullin A.E., Amorim M.J., Medcalf E., Tiley L.S., and Digard P. Temperature sensitive influenza A virus genome replication results from low thermal stability of polymerase-cRNA complexes. Virol. J. 3 (2006) 58
15. Enami M., and Enami K. Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J. Virol. 70 (1996) 6653-6657
16. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., Øymar K., Garcia M.L., Krygier A., Costa H., Heininger U., Pregaldien J.L., Cheng S.M., Skinner J., Razmpour A., Saville M., Gruber W.C., Forrest B., Group, and C.-T.A.S. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J. 25 (2006) 860-869
17. Fodor E., Crow M., Mingay L.J., Deng T., Sharps J., Fechter P., and Brownlee G.G. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J. Virol. 76 (2002) 8989-9001
18. Fodor E., Mingay L.J., Crow M., Deng T., and Brownlee G.G. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase promotes the generation of defective interfering RNAs. J. Virol. 77 (2003) 5017-5020
19. Fouchier R.A., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwaan G.F., Olsen B., and Osterhaus A.D. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79 5 (2005) 2814-2822
20. Gomez-Puertas P., Albo C., Perez-Pastrana E., Vivo A., and Portela A. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 74 (2000) 11538-11547
21. Gregoriade s.A., and Frangione B. Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion. J. Virol. 40 1 (1981) 323-328
22. Hara K., Schmidt F.I., Crow M., and Brownlee G.G. Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding. J. Virol. 80 16 (2006) 7789-7798
23. Herget M., and Scholtissek C. A temperature-sensitive mutation in the acidic polymerase gene of an influenza A virus alters the regulation of viral protein synthesis. J. Gen.Virol. 74 (1993) 1789-1794
24. Hirayama E., Atagi H., Hiraki A., and Kim J. Heat shock protein 70 is related to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex. J. Virol. 78 3 (2004) 1263-1270
25. Hoffmann E., Neumann G., Hobom G., Webster R.G., and Kawaoka Y. "Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 267 2 (2000) 310-317
26. Hoffmann E., Mahmood K., Chen Z., Yang C., Spaete J., Greenberg H.B., Herlocher M.L., Jin H., and Kemble G. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J. Virol. 79 17 (2005) 11014-11021
27. Kawaguchi A., Naito T., and Nagata K. Involvement of influenza virus PA subunit in assembly of functional RNA polymerase complexes. J. Virol. 79 (2005) 732-744
28. Lamb R.A., and Krug R.M. Orthomyxoviridae: the viruses and their replication. In: Knipe D.M., Howley P.M., et al. (Eds). Fields Virology 2 vols. (2001), Lippincott Williams & Wilkins, Philadelphia 1487-1531
29. Liu T., Muller J., and Ye Z. Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology. Virology 304 (2002) 89-96
30. Maassab H.F., and Bryant M.L. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev. Med. Virol. 9 4 (1999) 237-244
31. Maassab H.F., and DeBorde D.C. Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine 3 (1985) 355-369
32. Mandler J., Müller K., and Scholtissek C. Mutants and revertants of an avian influenza A virus with temperature-sensitive defects in the nucleoprotein and PB2. Virology 181 (1991) 512-519
33. McCullers J.A., Wang G.C., He S., and Webster R.G. Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J. Virol. 73 (1999) 7343-7348
34. McCullers J.A., Hoffmann E., Huber V.C., and Nickerson A. A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence. Virology 336 2 (2005) 318-326
35. Medcalf L., Poole E., Elton D., and Digard P. Temperature-sensitive lesions in two influenza A viruses defective for replicative transcription disrupt RNA binding by the nucleoprotein. J. Virol. 73 (1999) 7349-7356
36. Murphy B.R., and Coelingh K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral. Immunol. 15 2 (2002) 295-323
37. Nayak D.P., Hui E.K., and Barman S. Assembly and budding of influenza virus. Virus Res. 106 (2004) 147-165
38. Neumann G., Brownlee G., Fodor E., and Kawaoka Y. Orthomyxovirus replication, transcription, and polyadenylation. Curr. Top Microbiol. Immunol. 283 (2004) 121-143
39. Noton S.L., Medcalf E., Fisher D., Mullin A.E., Elton D., and Digard P. Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J. Gen. Virol. 88 Pt 8 (2007) 2280-2290
40. Odagiri T., Tanaka T., and Tobita K. Temperature-sensitive defect of influenza A/Ann Arbor/6/60 cold-adapted variant leads to a blockage of matrix polypeptide incorporation into the plasma membrane of the infected cells. Virus Res. 7 3 (1987) 203-218
41. Portela A., and Digard P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83 (2002) 723-734
42. Regan J.F., Liang Y., and Parslow T.G. Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA. J. Virol. 80 1 (2006) 252-261
43. Rota P., Wallis T.R., Harmon M.W., Rota J.S., Kendal A.P., and Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175 1 (1990) 59-68
44. Sakaguchi A., Hirayama E., Hiraki A., Ishida Y., and Kim J. Nuclear export of influenza viral ribonucleoprotein is temperature-dependently inhibited by dissociation of viral matrix protein. Virology 306 (2003) 244-253
45. Sha B., and Luo M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat. Struct. Biol. 4 (1997) 239-244
46. Simonsen L., Fukuda K., Schonberger L.B., and Cox N.J. The impact of influenza epidemics on hospitalizations. J. Infect. Dis. 181 (2000) 831-837
47. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., and Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
48. Watanabe K., Fuse T., Asano I., Tsukahara F., Maru Y., Nagata K., Kitazato K., and Kobayashi N. Identification of Hsc70 as an influenza virus matrix protein (M1) binding factor involved in the virus life cycle. FEBS Lett. 580 (2006) 5785-5790
49. Wright P.F., and Webster R.G. Orthomyxoviruses. In: Knipe D.M., Howley P.M., et al. (Eds). Fields Virology. Fourth ed 2 vols. (2001), Lippincott Williams & Wilkins, Philadelphia 1533-1579
50. Yasuda J., Toyoda T., Nakayama M., and Ishihama A. Regulatory effects of matrix protein variations on influenza virus growth. Arch. Virol. 133 (1993) 283-294
51. Ye Z., Liu T., Offringa D.P., McInnis J., and Levandowski R.A. Association of influenza virus matrix protein with ribonucleoproteins. J. Virol. 73 9 (1999) 7467-7473